Report Categories
View AllRecent Articles
View All
XRNA Chiron executives detail multifamily housing growth plans in latest quarterly earnings release
CL NWGL Stock Market Influencing Factors Weakens 20260420
BZFD BuzzFeed climbs 528 percent even after reporting a far wider than expected Q4 2025 loss
ONTF ON24 notches wide Q4 2025 EPS beat over analyst estimates with shares posting minor daily gains
Humana Inc HUM Rides SectorWide Rally Following UnitedHealth Q1 Earnings Beat
Traders Shift Expectations Fed Rate Hike Now Seen as More Likely by December
Dorchester DMLP Earnings Outlook Key Metrics for Q4 2024
Karyopharm Shares Slide as Q1 2026 Earnings Disappoint Investors
Anduril Secures 5 Billion Funding Round Valuation Soars to 61 Billion
Cadiz CDZI Stock Slides 416 Support at 394 20260520
Kazatomproms ThirdQuarter Production Surges 17 Reinforcing Uranium Market Momentum
Fox Corporation FOXA Q1 2026 Earnings EPS 132 Beats Estimates
Energy ESOA Stock Analysis Flat at 1743 Whats Next 20260521
Professional Title Medicare Fraud Conviction CEO Sentenced in 1 Billion Scheme Targeting Seniors
Morgan Wallens Im the Problem Achieves Milestone Sustained Chart Presence Signals LongTerm Revenue Potential
EID Parry Reports Q4 Net Loss on Exceptional Charge FY26 Profit at 1380 Crore
Micron Technology Surpasses 1 Trillion Market Cap Following UBS Price Target Upgrade
Entrepreneurs Overestimate AI Advantage as Competitors Quietly Gain Edge
Borosil Glass Works Shares Surge Over 200 in One Year on Strong Revenue Growth
Viavi Solutions VIAV Q1 2026 Earnings EPS Surges Past Estimates as Shares Rise
ONBPP Q1 2026 Earnings Slight EPS Miss Amid Stable Performance
TNDM Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively
ONL Q1 2026 Earnings Significant EPS Miss as Losses Widen
PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress
External Links
Bolivias Economic Policy Unrest Escalates Ministers Convoy Ambushed During Roadblock Clearance
RxSight Q1 2026 Earnings EPS Misses Estimates by 32 as Operational Costs Weigh
CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction
OGS Q1 2026 Earnings EPS Misses Expectations as Margin Pressures Mount
Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges
Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses
Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability
NKSH Q4 2025 Earnings Earnings Surprise of 2111 Driven by Strong Operating Performance
CLLS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue